CPRD – Page 2 – Boston Collaborative Drug Surveillance Program (BCDSP)

Safety of Apremilast in Patients with Psoriasis and Psoriatic Arthritis: Findings from the UK Clinical Practice Research Datalink

By BCDSP November 30, 2022CPRD, Drug Safety Studies, Safety of other important drugs

Journal: Drug Safety Authors: Rebecca Persson, Myriam Cordey, Maria Paris, Susan Jick NLM Citation: Persson R, Cordey M, Paris M, Jick S. Safety of Apremilast in Patients with Psoriasis and Psoriatic Arthritis: Findings…

Impact of von Willebrand Disease on Women’s Health Outcomes: A Matched Cohort Database Study

By BCDSP August 12, 2022CPRD, Disease Epidemiology Studies, Rare and understudied diseases, Select Publications

Journal: Journal of Women's Health Authors: Katrina Wilcox Hagberg, Susan Jick, Ping Du, Françoise Truong Berthoz, Gülden Özen, Spiros Tzivelekis NLM Citation: Hagberg KW, Jick S, Du P, Truong Berthoz F, Özen G, Tzivelekis S.…

Validation of autism spectrum disorder diagnoses recorded in the Clinical Practice Research Datalink, 1990-2014

By BCDSP September 15, 2017CPRD, Developmental Disabilities, Outcome and Exposure validation, Select Publications, Validation Studies

Journal: Clinical Epidemiology Authors: Katrina Wilcox Hagberg, Susan S Jick NLM Citation: Hagberg KW, Jick SS. Validation of autism spectrum disorder diagnoses recorded in the Clinical Practice Research Datalink, 1990-2014. Clin…

Antidepressant use during early pregnancy and the risk of congenital anomalies

By BCDSP June 6, 2013CPRD, Drug Safety Studies, Maternal and Child health, Mental Health, PhD Studies, Safety of drugs in pregnancy, Select Publications

Journal: Pharmacotherapy Authors: Catherine Vasilakis-Scaramozza, Ann Aschengrau, Howard Cabral, Susan S Jick NLM Citation: Vasilakis-Scaramozza C, Aschengrau A, Cabral H, Jick SS. Antidepressant use during early pregnancy and the risk of congenital anomalies.…